Literature DB >> 20930831

Medical microbiology: A toxin contest.

Jimmy D Ballard.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20930831     DOI： 10.1038/467665a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  11 in total

Review 1.  Clostridium difficile toxins: mechanism of action and role in disease.

Authors:  Daniel E Voth; Jimmy D Ballard
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

2.  Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies.

Authors:  D M Lyerly; C J Phelps; J Toth; T D Wilkins
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

3.  Glucosylation of Rho proteins by Clostridium difficile toxin B.

Authors:  I Just; J Selzer; M Wilm; C von Eichel-Streiber; M Mann; K Aktories
Journal:  Nature       Date:  1995-06-08       Impact factor: 49.962

4.  Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea.

Authors:  L Kyne; M Warny; A Qamar; C P Kelly
Journal:  Lancet       Date:  2001-01-20       Impact factor: 79.321

5.  The role of toxin A and toxin B in Clostridium difficile infection.

Authors:  Sarah A Kuehne; Stephen T Cartman; John T Heap; Michelle L Kelly; Alan Cockayne; Nigel P Minton
Journal:  Nature       Date:  2010-09-15       Impact factor: 49.962

6.  Rapid death of infant rhesus monkeys injected with Clostridium difficile toxins A and B: physiologic and pathologic basis.

Authors:  S S Arnon; D C Mills; P A Day; R V Henrickson; N M Sullivan; T D Wilkins
Journal:  J Pediatr       Date:  1984-01       Impact factor: 4.406

Review 7.  Treatment of Clostridium difficile infection.

Authors:  Dale N Gerding; Carlene A Muto; Robert C Owens
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

8.  The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins.

Authors:  I Just; M Wilm; J Selzer; G Rex; C von Eichel-Streiber; M Mann; K Aktories
Journal:  J Biol Chem       Date:  1995-06-09       Impact factor: 5.157

Review 9.  Clostridium difficile infection: new developments in epidemiology and pathogenesis.

Authors:  Maja Rupnik; Mark H Wilcox; Dale N Gerding
Journal:  Nat Rev Microbiol       Date:  2009-07       Impact factor: 60.633

10.  Toxin B is essential for virulence of Clostridium difficile.

Authors:  Dena Lyras; Jennifer R O'Connor; Pauline M Howarth; Susan P Sambol; Glen P Carter; Tongted Phumoonna; Rachael Poon; Vicki Adams; Gayatri Vedantam; Stuart Johnson; Dale N Gerding; Julian I Rood
Journal:  Nature       Date:  2009-03-01       Impact factor: 49.962
View more
  7 in total

1.  A small-molecule antivirulence agent for treating Clostridium difficile infection.

Authors:  Kristina Oresic Bender; Megan Garland; Jessica A Ferreyra; Andrew J Hryckowian; Matthew A Child; Aaron W Puri; David E Solow-Cordero; Steven K Higginbottom; Ehud Segal; Niaz Banaei; Aimee Shen; Justin L Sonnenburg; Matthew Bogyo
Journal:  Sci Transl Med       Date:  2015-09-23       Impact factor: 17.956

2.  Structural basis for antibody recognition in the receptor-binding domains of toxins A and B from Clostridium difficile.

Authors:  Tomohiko Murase; Luiz Eugenio; Melissa Schorr; Greg Hussack; Jamshid Tanha; Elena N Kitova; John S Klassen; Kenneth K S Ng
Journal:  J Biol Chem       Date:  2013-12-05       Impact factor: 5.157

3.  Automated detection of toxigenic Clostridium difficile in clinical samples: isothermal tcdB amplification coupled to array-based detection.

Authors:  Brian Hicke; Chris Pasko; Benjamin Groves; Edward Ager; Maylene Corpuz; Georges Frech; Denton Munns; Wendy Smith; Ashley Warcup; Gerald Denys; Nathan A Ledeboer; Wes Lindsey; Charles Owen; Larry Rea; Robert Jenison
Journal:  J Clin Microbiol       Date:  2012-06-06       Impact factor: 5.948

4.  Memory B Cells Encode Neutralizing Antibody Specific for Toxin B from the Clostridium difficile Strains VPI 10463 and NAP1/BI/027 but with Superior Neutralization of VPI 10463 Toxin B.

Authors:  T Scott Devera; Gillian A Lang; Jordi M Lanis; Pragya Rampuria; Casey L Gilmore; Judith A James; Jimmy D Ballard; Mark L Lang
Journal:  Infect Immun       Date:  2015-10-26       Impact factor: 3.441

5.  α-Galactosylceramide-Reactive NKT Cells Increase IgG1 Class Switch against a Clostridioides difficile Polysaccharide Antigen and Enhance Immunity against a Live Pathogen Challenge.

Authors:  Gillian A Lang; Binu Shrestha; Souwelimatou Amadou Amani; Tyler M Shadid; Jimmy D Ballard; Mark L Lang
Journal:  Infect Immun       Date:  2021-08-23       Impact factor: 3.441

6.  Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.

Authors:  Glen P Carter; Anjana Chakravorty; Tu Anh Pham Nguyen; Steven Mileto; Fernanda Schreiber; Lucy Li; Pauline Howarth; Simon Clare; Bliss Cunningham; Susan P Sambol; Adam Cheknis; Iris Figueroa; Stuart Johnson; Dale Gerding; Julian I Rood; Gordon Dougan; Trevor D Lawley; Dena Lyras
Journal:  MBio       Date:  2015-06-02       Impact factor: 7.867

7.  Importance of toxin A, toxin B, and CDT in virulence of an epidemic Clostridium difficile strain.

Authors:  Sarah A Kuehne; Mark M Collery; Michelle L Kelly; Stephen T Cartman; Alan Cockayne; Nigel P Minton
Journal:  J Infect Dis       Date:  2013-08-09       Impact factor: 5.226
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.